SRX246 is a potent, centrally penetrant, highly selective, and orally bioavailable vasopressin 1a (V1a) receptor antagonist (Ki = 0.3 nM for human V1a). It shows no interaction with V1b and V2 receptors and negligible binding to 64 other receptor types, including 35 G protein-coupled receptors. SRX246 can be used for the treatment of stress-related disorders.